| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118
Hypertension is associated with low plasma ascorbic acid levels and impaired endothelial function. Recent evidence suggests that increased vascular oxidative stress contributes to the pathophysiology of endothelial dysfunction and hypertension. We recently showed that chronic oral ascorbic acid therapy lowers blood pressure in hypertensive patients. We hypothesized that it would also improve endothelial vasomotor function. In a randomized, double-blind, placebo-controlled study, we examined the effect of acute (2 g po) and chronic (500 mg/day for 1 mo) ascorbic acid treatment on brachial artery flow-mediated dilation in 39 patients with hypertension. Compared with 82 age- and gender-matched normotensive controls, these patients had impaired endothelium-dependent, flow-mediated dilation of the brachial artery [8.9 ± 6.1 vs. 11.2 ± 5.7% (SD), P < 0.04]. After therapy, plasma ascorbic acid concentrations increased acutely from 50 ± 12 to 149 ± 51 µmol/l and were maintained at 99 ± 33 µmol/l with chronic treatment (both P < 0.001). As previously reported, chronic ascorbic acid therapy reduced systolic and mean blood pressure in these patients. However, acute or chronic ascorbic acid treatment had no effect on brachial artery endothelium-dependent, flow-mediated dilation or on endothelium-independent, nitroglycerin-mediated dilation. These results demonstrate that conduit vessel endothelial dysfunction secondary to hypertension is not reversed by acute or chronic treatment with oral ascorbic acid. The effects of this treatment on resistance vessel vasomotor function warrant further investigation.
antioxidants; endothelium-derived factors; nitric oxide
This article has been cited by other articles:
|
|
 |
|
  K. L. Jablonski, D. R. Seals, I. Eskurza, K. D. Monahan, and A. J. Donato High-dose ascorbic acid infusion abolishes chronic vasoconstriction and restores resting leg blood flow in healthy older men J Appl Physiol, November 1, 2007; 103(5): 1715 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Moreau, A. R. DePaulis, K. M. Gavin, and D. R. Seals Oxidative stress contributes to chronic leg vasoconstriction in estrogen-deficient postmenopausal women J Appl Physiol, March 1, 2007; 102(3): 890 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, X. Bian, S. W. Watts, and A. Hlavacova Activation of Vascular BK Channel by Tempol in DOCA-Salt Hypertensive Rats Hypertension, November 1, 2005; 46(5): 1154 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Munzel, A. Daiber, V. Ullrich, and A. Mulsch Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1551 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Moens, I. Goovaerts, M. J. Claeys, and C. J. Vrints Flow-Mediated Vasodilation: A Diagnostic Instrument, or an Experimental Tool? Chest, June 1, 2005; 127(6): 2254 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bell, J. M. Carson, N. W. Motte, and D. R. Seals Ascorbic acid does not affect the age-associated reduction in maximal cardiac output and oxygen consumption in healthy adults J Appl Physiol, March 1, 2005; 98(3): 845 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J., February 2, 2005; 26(4): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Violi, L Loffredo, L Musella, and A Marcoccia Should antioxidant status be considered in interventional trials with antioxidants? Heart, June 1, 2004; 90(6): 598 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing J. Physiol., April 1, 2004; 556(1): 315 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kinlay, D. Behrendt, J. C. Fang, D. Delagrange, J. Morrow, J. L. Witztum, N. Rifai, A. P. Selwyn, M. A. Creager, and P. Ganz long-term effect of combined vitamins e and c on coronary and peripheral endothelial function J. Am. Coll. Cardiol., February 18, 2004; 43(4): 629 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, G. D. Fink, and J. J. Galligan Tempol Lowers Blood Pressure and Sympathetic Nerve Activity But Not Vascular O2- in DOCA-Salt Rats Hypertension, February 1, 2004; 43(2): 329 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera Homocysteine and Essential Hypertension J. Clin. Pharmacol., December 1, 2003; 43(12): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Toumpoulis, C. E. Anagnostopoulos, and G. E. Drossos Reply to the editor J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1672 - 1672. [Full Text] [PDF]
|
|
|
|
|
|
G. E. Drossos, I. K. Toumpoulis, D. G. Katritsis, J. P. A. Ioannidis, P. Kontogiorgi, E. Svarna, and C. E. Anagnostopoulos Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 330 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K Dutta, et al. Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention J. Am. Coll. Nutr., February 1, 2003; 22(1): 18 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O. Bonetti, L. O. Lerman, and A. Lerman Endothelial Dysfunction: A Marker of Atherosclerotic Risk Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Mullan, I. S. Young, H. Fee, and D. R. McCance Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes Hypertension, December 1, 2002; 40(6): 804 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, G. D. Fink, and J. J. Galligan Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H885 - H892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kelm Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H1 - H5. [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, G. D. Fink, A. Chen, S. Watts, and J. J. Galligan Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H975 - H980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Duffy, J. F. Keaney Jr, M. Holbrook, N. Gokce, P. L. Swerdloff, B. Frei, and J. A. Vita Short- and Long-Term Black Tea Consumption Reverses Endothelial Dysfunction in Patients With Coronary Artery Disease Circulation, July 10, 2001; 104(2): 151 - 156. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
